CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations
CYIOS Corporation (OTC: CYIO) on October 29, 2025 engaged Atlanta Capital Partners to lead a renewed investor relations and capital markets program. The engagement aims to expand market visibility, strengthen liquidity, improve communications with institutional, family-office and retail investors, increase financial media exposure, and support CYIOS’s strategy to reduce legacy debt, pursue targeted healthcare supply acquisitions, scale its CyioIQ AI-powered SaaS platform, and progress toward OTCQB and Nasdaq qualifications.
CYIOS Corporation (OTC: CYIO) il 29 ottobre 2025 ha incaricato Atlanta Capital Partners di guidare un rinnovato programma di relazioni con gli investitori e di mercati dei capitali. L'incarico mira a aumentare la visibilità sul mercato, rafforzare la liquidità, migliorare la comunicazione con investitori istituzionali, di family office e al dettaglio, aumentare l'esposizione mediatica finanziaria e supportare la strategia di CYIOS di ridurre il debito legacy, perseguire acquisizioni mirate nel settore sanitario, scalare la sua piattaforma SaaS CyioIQ alimentata dall'IA, e progredire verso le qualifiche OTCQB e Nasdaq.
CYIOS Corporation (OTC: CYIO) el 29 de octubre de 2025 contrató a Atlanta Capital Partners para liderar un renovado programa de relaciones con los inversores y de mercados de capital. El objetivo del compromiso es ampliar la visibilidad en el mercado, fortalecer la liquidez, mejorar las comunicaciones con inversores institucionales, de oficinas familiares y minoristas, aumentar la exposición en los medios financieros y apoyar la estrategia de CYIOS de reducir la deuda heredada, buscar adquisiciones enfocadas en el suministro sanitario, escalar su plataforma SaaS CyioIQ impulsada por IA y avanzar hacia las calificaciones OTCQB y Nasdaq.
CYIOS Corporation (OTC: CYIO)는 2025년 10월 29일 Atlanta Capital Partners를 고용하여 투자자 관계 및 자본시장 프로그램을 새롭게 이끌었습니다. 이 계약의 목적은 시장 가시성을 확대하고 유동성을 강화하며 기관 투자자, 패밀리 오피스 및 소매 투자자와의 커뮤니케이션을 개선하고 금융 미디어 노출을 늘리며 CYIOS의 전략인 전통적 부채를 줄이고 목표 헬스케어 공급 인수를 추구하며 CyioIQ AI 기반 SaaS 플랫폼을 확장하고 OTCQB 및 나스닥 자격 취득으로 나아가는 것을 지원하는 것입니다.
CYIOS Corporation (OTC: CYIO) le 29 octobre 2025 a confié à Atlanta Capital Partners la conduite d'un programme renouvelé de relations avec les investisseurs et des marchés de capitaux. Cet engagement vise à accroître la visibilité sur le marché, renforcer la liquidité, améliorer les communications avec les investisseurs institutionnels, les family offices et les investisseurs de détail, augmenter l'exposition dans les médias financiers et soutenir la stratégie de CYIOS consistant à réduire sa dette héritée, à poursuivre des acquisitions ciblées dans le domaine des fournitures de soins de santé, à faire évoluer sa plateforme SaaS CyioIQ alimentée par l'IA et à progresser vers les qualifications OTCQB et Nasdaq.
CYIOS Corporation (OTC: CYIO) am 29. Oktober 2025 beauftragte Atlanta Capital Partners damit, ein erneuertes Programm für Investor Relations und Kapitalmärkte zu führen. Ziel der Beauftragung ist es, die Marktliquidität zu erhöhen, die Sichtbarkeit am Markt zu erweitern, die Kommunikation mit institutionellen Investoren, Family Offices und Privatanlegern zu verbessern, die finanzielle Medienexposition zu steigern und CYIOS’ Strategie zu unterstützen, die Altlasten zu reduzieren, gezielte Akquisitionen im Bereich Gesundheitsversorgung zu tätigen, seine von KI angetriebene SaaS-Plattform CyioIQ zu skalieren und Fortschritte bei der Qualifikation für OTCQB und Nasdaq zu machen.
CYIOS Corporation (OTC: CYIO) في 29 أكتوبر 2025 تعهدت بالتعاون مع Atlanta Capital Partners بقيادة برنامج علاقات المستثمرين وأسواق رأس المال المجدد. يهدف الالتزام إلى توسيع الرؤية السوقية، تقوية السيولة، تحسين الاتصالات مع المستثمرين المؤسسيين ومكاتب العائلة والمستثمرين الأفراد، زيادة التعرض الإعلامي المالي، ودعم استراتيجية CYIOS في تقليل الدين المتوارث، والسعي لعمليات استحواذ مستهدفة في مجال الإمدادات الصحية، وتطوير منصتها CyioIQ المعتمدة على الذكاء الاصطناعي كخدمة SaaS، والتقدم نحو مؤهلات OTCQB و Nasdaq.
CYIOS Corporation (OTC: CYIO) 于 2025年10月29日 委任 Atlanta Capital Partners 主导更新的投资者关系与资本市场计划。此次任命旨在提升市场知名度、增强流动性、改善与机构投资者、家族办公室投资者及散户投资者的沟通、提升金融媒体曝光度，并支持 CYIOS 的战略，即减少历史遗留债务、追求针对性的医疗保健供应并购、扩展其 CyioIQ AI 驱动的 SaaS 平台、并推进 OTCQB 与 Nasdaq 的资格认证。
- None.
- None.
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the “Company”), a Nevada-registered holding company focused on acquisitions, modernization and technology integration in the healthcare and medical supply sectors, today announced it has engaged Atlanta Capital Partners, LLC to lead a renewed investor relations strategy designed to expand CYIOS’s visibility and enhance communication across the investment community.
Atlanta Capital Partners, founded in 2004, is a proactive investor relations and capital markets advisory firm with extensive experience assisting public companies in elevating market awareness, strengthening liquidity, and clearly communicating business execution and strategic value to Wall Street, global investors, and national media outlets.
“We are entering a significant period of growth driven by our strategy to reduce legacy debt, advance targeted healthcare acquisitions and scale our AI-powered SaaS platform, CyioIQ,” said John O’Shea, Chairman and CEO of CYIOS. “Partnering with Atlanta Capital Partners will help ensure our transformation and progress are recognized throughout the wider investment landscape as we work toward operational excellence and a future Nasdaq uplisting.”
CYIOS’s current strategic plan includes expanding cash flow through acquisition of healthcare supply companies, modernizing and digitizing operations through the CyioIQ platform, and progressing toward OTCQB and Nasdaq qualifications supported by a strengthened balance sheet.
David Kugelman, President of Atlanta Capital Partners, LLC, stated, “CYIOS has a defined roadmap focused on measurable execution and value creation. Our program will help elevate the Company’s profile among investors who are actively seeking transformation-stage opportunities within high-demand sectors such as healthcare technology.”
Under the partnership, Atlanta Capital Partners will collaborate directly with CYIOS management to execute a fully compliant investor relations and capital markets communication program. Key initiatives include expanded outreach to institutional, family-office and retail investors, consistent distribution of corporate updates, increased financial media exposure, and strategic event participation, all aimed at building market understanding of CYIOS’s growth trajectory.
About CYIOS Corporation LLC
CYIOS Corporation (OTC: CYIO) is a diversified holding company focused on building, acquiring, and operating innovative businesses across multiple industries, including medical supplies, technology, and fintech. Through its subsidiary Noir Medical Supplies, CYIOS continues to expand its presence in the U.S. medical distribution sector, emphasizing operational excellence and sustainable profitability.
About Atlanta Capital Partners, LLC
Atlanta Capital Partners, LLC, founded in 2004, is an investor relations and capital markets advisory firm that provides strategic communications, proactive investor outreach, capital markets guidance and advisory support for public companies. The benchmark of the firm’s success is measured by the success of its clients.
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of applicable securities legislation. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions, opinions and estimates of management and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of regulatory agencies and regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise, except as required by applicable law.
Media & Investor Relations Contact
David Kugelman
Atlanta Capital Partners, LLC
(866) 692-6847 (U.S. & Canada Toll-Free)
(404) 281-8556 (Mobile / WhatsApp)
dk@atlcp.com
FAQ
What did CYIOS (OTC: CYIO) announce on October 29, 2025 about investor relations?
Who will lead CYIOS’s investor relations efforts and what is their experience?
How will Atlanta Capital Partners support CYIOS’s Nasdaq progression for CYIO?
What strategic priorities did CYIOS (CYIO) say the IR program will highlight?
Will the Atlanta Capital Partners engagement change how CYIOS distributes corporate updates for CYIO stockholders?
Does the announcement disclose any signed acquisitions or financial targets for CYIOS (CYIO)?
